Company intelligence / Profile preview
Chengdu Kanghong Biotechnology Co., Ltd.
Chengdu, Sichuan, Chinaen.cnkh.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Chengdu Kanghong Biotechnology has commercialized several drugs in China—most notably conbercept/Lumitin® for retinal diseases. Conbercept has completed global Phase III trials with FDA and EMA engagement. The pipeline includes next-generation biologics and dual-payload ADCs targeting both ophthalmology and oncology indications. Early clinical data on new assets such as KH815 are emerging.
- Therapeutic areas
- OncologyPsychiatryCardiovascularOphthalmology
- Modalities
- Antibody fusion proteinsDual payload antibody-drug conjugates (ADCs)Bispecific antibodiesHerbal medicines
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Distribution partnership with Israeli firm IOPtima via parent group; no major disclosed pharma partnerships at biotech subsidiary level.
Beyond the preview
Go deeper on Chengdu Kanghong Biotechnology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chengdu Kanghong Biotechnology Co., Ltd..